275 related articles for article (PubMed ID: 10520611)
21. Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States.
Houghton R; Ong RC; Bolognani F
Autism Res; 2017 Dec; 10(12):2037-2047. PubMed ID: 28963809
[TBL] [Abstract][Full Text] [Related]
22. Early diagnoses and psychotherapeutic medication treatment experiences of a cohort of children under 6 years old who received antipsychotic treatment in Florida's Medicaid program.
Constantine RJ; Tandon R; McPherson M; Andel R
J Child Adolesc Psychopharmacol; 2011 Feb; 21(1):79-84. PubMed ID: 21288122
[TBL] [Abstract][Full Text] [Related]
23. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
[TBL] [Abstract][Full Text] [Related]
24. Psychotropic Medication Utilization Among Children Diagnosed With Fetal Alcohol Spectrum Disorder.
Senturias Y; Ali MM; West K
Pediatrics; 2022 Oct; 150(4):. PubMed ID: 36164844
[TBL] [Abstract][Full Text] [Related]
25. Characterization of Chronic Multiclass Psychotropic Polypharmacy and Psychotherapy in Foster Care Youth in a State Medicaid Population.
Keast SL; Tidmore LM; Shropshire D; Nesser N; Lambert TL
J Manag Care Spec Pharm; 2019 Dec; 25(12):1340-1348. PubMed ID: 31778625
[TBL] [Abstract][Full Text] [Related]
26. Risk of Injury According to Attention Deficit Hyperactivity Disorder, Comorbid Mental Illness, and Medication Therapy.
Merrill RM; Thygerson SM; Palmer CA
Pharmacopsychiatry; 2016 Mar; 49(2):45-50. PubMed ID: 26829453
[TBL] [Abstract][Full Text] [Related]
27. Variations in pharmacotherapy for attention deficit hyperactivity disorder in managed care.
Boles M; Lynch FL; DeBar LL
J Child Adolesc Psychopharmacol; 2001; 11(1):43-52. PubMed ID: 11322744
[TBL] [Abstract][Full Text] [Related]
28. Medicaid Prior Authorization Policies for Medication Treatment of Attention-Deficit/Hyperactivity Disorder in Young Children, United States, 2015.
Hulkower RL; Kelley M; Cloud LK; Visser SN
Public Health Rep; 2017; 132(6):654-659. PubMed ID: 29072963
[TBL] [Abstract][Full Text] [Related]
29. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth.
Moreno C; Laje G; Blanco C; Jiang H; Schmidt AB; Olfson M
Arch Gen Psychiatry; 2007 Sep; 64(9):1032-9. PubMed ID: 17768268
[TBL] [Abstract][Full Text] [Related]
30. Correlating Psychotropic Use to Major Depressive Disorder and ADHD Research Diagnoses: Trends in a Prospective Pediatric Cohort From Ages 3 to 21.
Liang MU; Charatcharungkiat N; Tillman R; Patel HM; Vogel AC; Luby JL
J Clin Psychiatry; 2022 Oct; 83(6):. PubMed ID: 36321921
[No Abstract] [Full Text] [Related]
31. Injury-proneness of youth with attention-deficit hyperactivity disorder: a national clinical data analysis in Taiwan.
Tai YM; Gau SS; Gau CS
Res Dev Disabil; 2013 Mar; 34(3):1100-8. PubMed ID: 23340027
[TBL] [Abstract][Full Text] [Related]
32. Patterns of Early Mental Health Diagnosis and Medication Treatment in a Medicaid-Insured Birth Cohort.
Pennap D; Zito JM; Santosh PJ; Tom SE; Onukwugha E; Magder LS
JAMA Pediatr; 2018 Jun; 172(6):576-584. PubMed ID: 29710205
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology of Treatment for Preschoolers on Kentucky Medicaid Diagnosed with Attention-Deficit/Hyperactivity Disorder.
Davis DW; Feygin Y; Creel L; Kong M; Jawad K; Sun J; Blum NJ; Lohr WD; Williams PG; Le J; Jones VF; Pasquenza N
J Child Adolesc Psychopharmacol; 2020 Sep; 30(7):448-455. PubMed ID: 32614247
[No Abstract] [Full Text] [Related]
34. Use of Medication to Treat Attention-Deficit/Hyperactivity Disorder in Young Children: The Role of Maternal History of Psychotropic Medication Use.
Wall-Wieler E; Bolton JM; Detillieux G; Roos LL
Child Psychiatry Hum Dev; 2023 Apr; 54(2):283-289. PubMed ID: 34524582
[TBL] [Abstract][Full Text] [Related]
35. Exposure to Surgery and Anesthesia in Early Childhood and Subsequent Use of Attention Deficit Hyperactivity Disorder Medications.
Ing C; Ma X; Sun M; Lu Y; Wall MM; Olfson M; Li G
Anesth Analg; 2020 Sep; 131(3):723-733. PubMed ID: 31923004
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
Goldman LS; Genel M; Bezman RJ; Slanetz PJ
JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
[TBL] [Abstract][Full Text] [Related]
37. Outpatient Visits and Medication Prescribing for US Children With Mental Health Conditions.
Anderson LE; Chen ML; Perrin JM; Van Cleave J
Pediatrics; 2015 Nov; 136(5):e1178-85. PubMed ID: 26459647
[TBL] [Abstract][Full Text] [Related]
38. ADHD Treatment in Primary Care: Demographic Factors, Medication Trends, and Treatment Predictors.
Hauck TS; Lau C; Wing LLF; Kurdyak P; Tu K
Can J Psychiatry; 2017 Jun; 62(6):393-402. PubMed ID: 28103079
[TBL] [Abstract][Full Text] [Related]
39. Changing patterns of conditions among children receiving Supplemental Security Income disability benefits.
Perrin JM; Kuhlthau K; McLaughlin TJ; Ettner SL; Gortmaker SL
Arch Pediatr Adolesc Med; 1999 Jan; 153(1):80-4. PubMed ID: 9895004
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder.
Frazier TW; Shattuck PT; Narendorf SC; Cooper BP; Wagner M; Spitznagel EL
J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):571-9. PubMed ID: 22166171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
